Insulet
PODD
#1048
Rank
C$25.69 B
Marketcap
$366.35
Share price
-1.72%
Change (1 day)
47.47%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2023 (TTM): $2.32

According to Insulet's latest financial reports the company's current EPS (TTM) is $2.41. In 2022 the company made an earnings per share (EPS) of $0.09788 a decrease over its 2021 EPS that were of $0.32.

EPS history for Insulet from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.322271.69%
2022$0.09788-69.57%
2021$0.32109.09%
2020$0.15-38.89%
2019$0.25200%
2018$0.08390-113.04%
2017-$0.64-9.8%
2016-$0.71-60.77%
2015-$1.8239.78%
2014-$1.3012.05%
2013-$1.16-23.15%
2012-$1.5110.2%
2011-$1.37-36.36%
2010-$2.15-36.63%
2009-$3.40-29.36%
2008-$4.81-86.74%
2007-$36.28-64.04%
2006-$100.89122.23%
2005-$45.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.82-217.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.52-287.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.37-43.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.70 718.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.16 72.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.80 58.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$7.59 215.66%๐Ÿ‡บ๐Ÿ‡ธ USA